Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8344)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yamagiwa S, Kamimura H, Takamura M, Aoyagi Y. Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance. World J Gastroenterol 2014; 20(10): 2606-2612 [PMID: 24627596 DOI: 10.3748/wjg.v20.i10.2606] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i10/2606.htm |
| Number | Citing Articles |
| 1 |
Raj A Shah, Kris V Kowdley. Current and potential treatments for primary biliary cholangitis. The Lancet Gastroenterology & Hepatology 2020; 5(3): 306 doi: 10.1016/S2468-1253(19)30343-7
|
| 2 |
|
| 3 |
Paschalis Chatzipantelis, Alexandra Giatromanolaki. Early histopathologic changes in primary biliary cholangitis: does ‘minimal change’ primary biliary cholangitis exist? A pathologist’s view. European Journal of Gastroenterology & Hepatology 2021; 33(12): e7 doi: 10.1097/MEG.0000000000001876
|
| 4 |
Wei Huang, Tianyu Jin, Wei Zheng, Qiaoqiao Yin, Qiqi Yan, Hongying Pan, Chengan Xu. Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases. Journal of Autoimmunity 2024; 145: 103188 doi: 10.1016/j.jaut.2024.103188
|
| 5 |
Alicja Bauer, Andrzej Habior, Damian Gawel. Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis. Biomedicines 2022; 10(4): 801 doi: 10.3390/biomedicines10040801
|
| 6 |
Ahmad H. Ali, James H. Tabibian, Elizabeth J. Carey, Keith D. Lindor. Emerging drugs for the treatment of Primary Biliary Cholangitis. Expert Opinion on Emerging Drugs 2016; 21(1): 39 doi: 10.1517/14728214.2016.1150999
|
| 7 |
Hyun Jin Cha, Jimin Hwang, Lucy Eunju Lee, Younhee Park, Jason Jungsik Song, Gianfranco D. Alpini. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease. PLOS ONE 2021; 16(1): e0244950 doi: 10.1371/journal.pone.0244950
|
| 8 |
Naoki Takahashi, Takako Saeki, Atsushi Komatsuda, Chishio Munemura, Takeaki Fukui, Naofumi Imai, Noriyuki Homma, Tsuguru Hatta, Ken-ichi Samejima, Takashi Fujimoto, Hiroki Omori, Yumi Ito, Yudai Nishikawa, Mamiko Kobayashi, Yukie Morikawa, Sachiko Fukushima, Seiji Yokoi, Daisuke Mikami, Kenji Kasuno, Hideki Kimura, Tomoyuki Nemoto, Yasunari Nakamoto, Kiyonao Sada, Manabu Sugai, Hironobu Naiki, Haruyoshi Yoshida, Ichiei Narita, Yoshihiko Saito, Masayuki Iwano. Tubulointerstitial Nephritis with IgM-Positive Plasma Cells. Journal of the American Society of Nephrology 2017; 28(12): 3688 doi: 10.1681/ASN.2016101074
|
| 9 |
Øystein Fluge, Olav Mella, Ove Bruland, Kristin Risa, Sissel E. Dyrstad, Kine Alme, Ingrid G. Rekeland, Dipak Sapkota, Gro V. Røsland, Alexander Fosså, Irini Ktoridou-Valen, Sigrid Lunde, Kari Sørland, Katarina Lien, Ingrid Herder, Hanne Thürmer, Merete E. Gotaas, Katarzyna A. Baranowska, Louis M.L.J. Bohnen, Christoph Schäfer, Adrian McCann, Kristian Sommerfelt, Lars Helgeland, Per M. Ueland, Olav Dahl, Karl J. Tronstad. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight 2016; 1(21) doi: 10.1172/jci.insight.89376
|
| 10 |
Zeineb Zian, S.P. Déo-Gracias Berry, Nazila Bahmaie, Dana Ghotbi, Ali Kashif, Manisha Madkaikar, Umair Ahmed Bargir, Hamisu Abdullahi, Haroon Khan, Gholamreza Azizi. The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies. International Immunopharmacology 2021; 95: 107565 doi: 10.1016/j.intimp.2021.107565
|
| 11 |
Yuxin Liu, Jianghong Yu, Zachary Oaks, Ivan Marchena-Mendez, Lisa Francis, Eduardo Bonilla, Phillip Aleksiejuk, Jessica Patel, Katalin Banki, Steve K. Landas, Andras Perl. Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. Clinical Immunology 2015; 160(2): 319 doi: 10.1016/j.clim.2015.07.001
|
| 12 |
Wen-Tao Ma, De-Kun Chen. Immunological abnormalities in patients with primary biliary cholangitis. Clinical Science 2019; 133(6): 741 doi: 10.1042/CS20181123
|
| 13 |
Caterina Maria Gambino, Luisa Agnello, Vincenza Calvaruso, Rosaria Vincenza Giglio, Luigi Capodicasa, Concetta Scazzone, Giuseppina Candore, Fabio Del Ben, Vito Di Marco, Marcello Ciaccio. Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience. Clinica Chimica Acta 2025; 566: 120037 doi: 10.1016/j.cca.2024.120037
|
| 14 |
Valentina Guatibonza-García, Paula Valentina Gaete, Agustín Pérez-Londoño, Danna Kathalina Puerto-Baracaldo, Sebastián Antonio Gutiérrez-Romero, Carlos O Mendivil, Monica Tapias. Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: A single-center study. World Journal of Gastroenterology 2021; 27(29): 4890-4899 doi: 10.3748/wjg.v27.i29.4890
|
| 15 |
Henry H. Nguyen, Abdel Aziz Shaheen, Natalia Baeza, Ellina Lytvyak, Stefan J. Urbanski, Andrew L. Mason, Gary L. Norman, Marvin J. Fritzler, Mark G. Swain, Gianfranco D. Alpini. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS). PLOS ONE 2018; 13(3): e0193960 doi: 10.1371/journal.pone.0193960
|
| 16 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, KAZUNORI FUGO, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, TAKASHI KISHIMOTO, NAOKI ISHIGE. Anti-mitochondrial M2 antibody-positive autoimmune hepatitis. Experimental and Therapeutic Medicine 2015; 10(4): 1419 doi: 10.3892/etm.2015.2694
|
| 17 |
Treta Purohit, Mitchell S Cappell. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World Journal of Hepatology 2015; 7(7): 926-941 doi: 10.4254/wjh.v7.i7.926
|
| 18 |
I. Franco, A. Dubini, S. Piciucchi, G. Casoni, V. Poletti. Interstitial lung disease preceding primary biliary cirrhosis in a male patient. Revista Portuguesa de Pneumologia (English Edition) 2015; 21(4): 214 doi: 10.1016/j.rppnen.2015.02.008
|
| 19 |
Hao Li, Yanling Guan, Chenchen Han, Yu Zhang, Qian Liu, Wei Wei, Yang Ma. The pathogenesis, models and therapeutic advances of primary biliary cholangitis. Biomedicine & Pharmacotherapy 2021; 140: 111754 doi: 10.1016/j.biopha.2021.111754
|
| 20 |
Ying-Qiu Huang. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World Journal of Hepatology 2016; 8(33): 1419-1441 doi: 10.4254/wjh.v8.i33.1419
|
| 21 |
Wei Zhang, Jung-hyun Rho, Michael H. Roehrl, Julia Y. Wang. A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins. BMC Immunology 2019; 20(1) doi: 10.1186/s12865-019-0304-1
|
| 22 |
Ralf Weiskirchen, Sabine Weiskirchen, Frank Tacke. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Research 2018; 7: 921 doi: 10.12688/f1000research.14841.1
|
| 23 |
Alexander J. Kovalic, Herbert L. Bonkovsky. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 9 doi: 10.1007/978-3-030-33628-8_2
|
| 24 |
Francesco Martini, Daniele Balducci, Martina Mancinelli, Valerio Buzzanca, Elena Fracchia, Giuseppe Tarantino, Antonio Benedetti, Marco Marzioni, Luca Maroni. Risk Stratification in Primary Biliary Cholangitis. Journal of Clinical Medicine 2023; 12(17): 5713 doi: 10.3390/jcm12175713
|
| 25 |
B. D. Chaltsev, V. I. Vasilyev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, T. N. Safonova, E. V. Rodionova, I. V. Gaiduk, L. L. Borozdkin. CLINICAL AND LABORATORY FEATURES OF ANTICENTROMERE ANTIBODY-POSITIVE SJö GREN’S SYNDROME. Rheumatology Science and Practice 2019; 57(4): 431 doi: 10.14412/1995-4484-2019-431-439
|
| 26 |
Won-Tak Choi, Ryan M. Gill. Pathologic features and differential diagnosis of chronic hepatitis. Diagnostic Histopathology 2023; 29(1): 12 doi: 10.1016/j.mpdhp.2022.10.003
|
| 27 |
Tingwang Jiang, Xiaoli Xiang, Xudong Wang, Zhijun Han, Cuie Cheng, Yuehong Zhu, Zaixing Yang, Yan Liang. Regulatory T Cells and Autoimmune Diseases. 2024; : 433 doi: 10.1016/B978-0-443-13947-5.00014-2
|
| 28 |
Alessandro P. Delitala, Giovanni M. Pes, Giuseppe Fanciulli, Margherita Maioli, Giannina Secchi, Franca Sanciu, Giuseppe Delitala, Roberto Manetti. Organ-specific antibodies in LADA patients for the prediction of insulin dependence. Endocrine Research 2016; 41(3): 207 doi: 10.3109/07435800.2015.1136934
|
| 29 |
Melissa Palmer, Arie Regev, Keith Lindor, Mark I. Avigan, Lara Dimick‐Santos, William Treem, John F. Marcinak, James H. Lewis, Frank A. Anania, Daniel Seekins, Benjamin L. Shneider, Naga Chalasani. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Alimentary Pharmacology & Therapeutics 2020; 51(1): 90 doi: 10.1111/apt.15579
|
| 30 |
Francesca Colapietro, Ana Lleo, Elena Generali. Antimitochondrial Antibodies: from Bench to Bedside. Clinical Reviews in Allergy & Immunology 2021; 63(2): 166 doi: 10.1007/s12016-021-08904-y
|
| 31 |
Alicja Bauer, Andrzej Habior. Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis. Annals of Laboratory Medicine 2019; 39(3): 291 doi: 10.3343/alm.2019.39.3.291
|
| 32 |
Tiannan Zhou, Huixian Wei, Jinjun Wang, Sudhir Kumar Rai. Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid. PLOS ONE 2023; 18(2): e0279431 doi: 10.1371/journal.pone.0279431
|
| 33 |
Shirley R. R. Utiyama, Katiane B. Zenatti, Heloisa A. J. Nóbrega, Juliana Z. C. Soares, Thelma L. Skare, Caroline Matsubara, Dominique A. Muzzilo, Renato M. Nisihara. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases. Immunological Investigations 2016; 45(6): 566 doi: 10.1080/08820139.2016.1186173
|
| 34 |
Qian Zhang, Zhiqiang Liu, Shanshan Wu, Weijia Duan, Sha Chen, Xiaojuan Ou, Hong You, Yuanyuan Kong, Jidong Jia. Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/8959103
|
| 35 |
Elisabet Poyatos, Francisco Morandeira, Joan Climent, Virginia Mas, José Castellote, Jordi Bas. Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis. Clinical Immunology 2024; 268: 108749 doi: 10.1016/j.clim.2021.108749
|
| 36 |
Albert Parés. Practical management of primary biliary cholangitis. Revista Española de Enfermedades Digestivas 2021; doi: 10.17235/reed.2021.8219/2021
|
| 37 |
Ji-Won Park, Jung-Hee Kim, Sung-Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Hyoung-Su Kim, Ki Tae Suk, Dong Joon Kim. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022; 10(6): 1288 doi: 10.3390/biomedicines10061288
|
| 38 |
Eszter Szabo, Balint Nagy, Andras Czajlik, Timea Komlodi, Oliver Ozohanics, Laszlo Tretter, Attila Ambrus. Macromolecular Protein Complexes V. Subcellular Biochemistry 2024; 104: 295 doi: 10.1007/978-3-031-58843-3_13
|
| 39 |
Olwyn Byron, John Gordon Lindsay. Macromolecular Protein Complexes. Subcellular Biochemistry 2017; 83: 523 doi: 10.1007/978-3-319-46503-6_19
|
| 40 |
Christopher Chang, Atsushi Tanaka, M. Eric Gershwin. Unmet needs in autoimmune liver diseases. Journal of Digestive Diseases 2019; 20(7): 327 doi: 10.1111/1751-2980.12785
|
| 41 |
Natalia M. Krajewska, Rémi Fiancette, Ye H. Oo. Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies. International Journal of Molecular Sciences 2022; 23(11): 5872 doi: 10.3390/ijms23115872
|
| 42 |
Eunhee Han, Sung Jin Jo, Hyeyoung Lee, Ae-Ran Choi, Jihyang Lim, Eun-Sun Jung, Eun-Jee Oh. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis. Clinica Chimica Acta 2017; 464: 113 doi: 10.1016/j.cca.2016.11.021
|
| 43 |
Sumio Minamiyama, Sakiho Ueda, Ran Nakashima, Hodaka Yamakado, Yusuke Sakato, Hirofumi Yamashita, Nobukatsu Sawamoto, Ryota Fujimoto, Ichizo Nishino, Makoto Urushitani, Tsuneyo Mimori, Ryosuke Takahashi. Thigh muscle MRI findings in myopathy associated with anti‐mitochondrial antibody. Muscle & Nerve 2020; 61(1): 81 doi: 10.1002/mus.26731
|
| 44 |
Xiaoli Zeng, Siting Li, Shiyi Tang, Xi Li, Guoyuan Zhang, Mengtao Li, Xiaofeng Zeng, Chaojun Hu. Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.669137
|
| 45 |
Alicja Bauer, Tomasz Rawa. Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis. International Journal of Molecular Sciences 2024; 25(2): 1333 doi: 10.3390/ijms25021333
|
| 46 |
Lisa Florin, Kaat Rubben, Amber Vanhaecke, Katrien Devreese, Filip De Keyser, Vanessa Smith, Carolien Bonroy. Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients. Clinical Chemistry and Laboratory Medicine (CCLM) 2020; 58(3): 416 doi: 10.1515/cclm-2019-0655
|